메뉴 건너뛰기




Volumn 111, Issue 9, 2014, Pages 1699-1716

Co-opting biology to deliver drugs

Author keywords

Albumin; Drug delivery; Erythrocyte; Exosome; Fc fusion; Folic acid; Lipoprotein; Macrophage; Platelet; Transferrin

Indexed keywords

BIOMOLECULES; LIPOPROTEINS; MACROPHAGES; MOLECULES; ORGANIC ACIDS; PLATELETS;

EID: 84905010074     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25307     Document Type: Review
Times cited : (66)

References (199)
  • 1
    • 0141727870 scopus 로고    scopus 로고
    • Safety and utilization of blood components as therapeutic delivery systems
    • Adams T, Alanazi F, Lu DR. 2003. Safety and utilization of blood components as therapeutic delivery systems. Curr Pharm Biotechnol 4(5):275-282.
    • (2003) Curr Pharm Biotechnol , vol.4 , Issue.5 , pp. 275-282
    • Adams, T.1    Alanazi, F.2    Lu, D.R.3
  • 2
    • 84877948067 scopus 로고    scopus 로고
    • Red blood cell-encapsulated l-asparaginase: Potential Therapy of patients with asparagine synthetase deficient acute myeloid leukemia
    • Agrawal V, Hee Woo J, Borthakur G, Kantarjian HE, Frankel A. 2013. Red blood cell-encapsulated l-asparaginase: Potential Therapy of patients with asparagine synthetase deficient acute myeloid leukemia. Protein Pept Lett 20(4):392-402.
    • (2013) Protein Pept Lett , vol.20 , Issue.4 , pp. 392-402
    • Agrawal, V.1    Hee Woo, J.2    Borthakur, G.3    Kantarjian, H.E.4    Frankel, A.5
  • 3
    • 79960405094 scopus 로고    scopus 로고
    • Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study
    • Alanazi F, Harisa G-D, Maqboul A, Abdel-Hamid M, Neau S, Alsarra I. 2011. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study. Arch Pharm Res 34(4):563-571.
    • (2011) Arch Pharm Res , vol.34 , Issue.4 , pp. 563-571
    • Alanazi, F.1    Harisa, G.-D.2    Maqboul, A.3    Abdel-Hamid, M.4    Neau, S.5    Alsarra, I.6
  • 4
    • 0036527585 scopus 로고    scopus 로고
    • Molecular mechanisms of lymphangiogenesis in health and disease
    • Alitalo K, Carmeliet P. 2002. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1(3):219-227.
    • (2002) Cancer Cell , vol.1 , Issue.3 , pp. 219-227
    • Alitalo, K.1    Carmeliet, P.2
  • 5
    • 79953858598 scopus 로고    scopus 로고
    • Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
    • Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341-345.
    • (2011) Nat Biotechnol , vol.29 , Issue.4 , pp. 341-345
    • Alvarez-Erviti, L.1    Seow, Y.2    Yin, H.3    Betts, C.4    Lakhal, S.5    Wood, M.6
  • 7
    • 33745508741 scopus 로고    scopus 로고
    • Perspective-FcRn transports albumin: Relevance to immunology and medicine
    • Anderson C, Chaudhury C, Kim J, Bronson C, Wani M, Mohanty S. 2006. Perspective-FcRn transports albumin: Relevance to immunology and medicine. Trends Immunol 27(7):343-348.
    • (2006) Trends Immunol , vol.27 , Issue.7 , pp. 343-348
    • Anderson, C.1    Chaudhury, C.2    Kim, J.3    Bronson, C.4    Wani, M.5    Mohanty, S.6
  • 8
    • 0026652116 scopus 로고
    • The biological chemistry of folate receptors
    • Antony AC. 1992. The biological chemistry of folate receptors. Blood 79(11):2807-2820.
    • (1992) Blood , vol.79 , Issue.11 , pp. 2807-2820
    • Antony, A.C.1
  • 9
    • 4344667831 scopus 로고    scopus 로고
    • A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
    • Baggio L, Huang Q, Brown T, Drucker D. 2004. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 53(9):2492-2500.
    • (2004) Diabetes , vol.53 , Issue.9 , pp. 2492-2500
    • Baggio, L.1    Huang, Q.2    Brown, T.3    Drucker, D.4
  • 10
    • 85007042722 scopus 로고
    • Fusion proteins containing n-terminal fragments of human serum albumin
    • Ballance DJ. 1993. Fusion proteins containing n-terminal fragments of human serum albumin. Google Patents.
    • (1993) Google Patents
    • Ballance, D.J.1
  • 12
    • 0345357073 scopus 로고    scopus 로고
    • Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery
    • Bellocq NC, Pun SH, Jensen GS, Davis ME. 2003. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 14(6):1122-1132.
    • (2003) Bioconjug Chem , vol.14 , Issue.6 , pp. 1122-1132
    • Bellocq, N.C.1    Pun, S.H.2    Jensen, G.S.3    Davis, M.E.4
  • 13
    • 0017752970 scopus 로고
    • Enzyme replacement therapy in Gaucher's disease: Preliminary clinical trial of a new enzyme preparation
    • Beutler E, Dale G, Guinto D, Kuhl W. 1977. Enzyme replacement therapy in Gaucher's disease: Preliminary clinical trial of a new enzyme preparation. Proc Natl Acad Sci USA 74(10):4620-4623.
    • (1977) Proc Natl Acad Sci USA , vol.74 , Issue.10 , pp. 4620-4623
    • Beutler, E.1    Dale, G.2    Guinto, D.3    Kuhl, W.4
  • 15
    • 67650388093 scopus 로고    scopus 로고
    • Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis
    • Bracewell C, Isaacs J, Emery P, Ng W. 2009. Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis. Expert Opin Biol Ther 9(7):909-919.
    • (2009) Expert Opin Biol Ther , vol.9 , Issue.7 , pp. 909-919
    • Bracewell, C.1    Isaacs, J.2    Emery, P.3    Ng, W.4
  • 17
    • 70349835152 scopus 로고    scopus 로고
    • Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes
    • Briones E, Colino CI, Millán CG, Lanao JM. 2009. Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes. Eur J Pharm Sci 38(4):320-324.
    • (2009) Eur J Pharm Sci , vol.38 , Issue.4 , pp. 320-324
    • Briones, E.1    Colino, C.I.2    Millán, C.G.3    Lanao, J.M.4
  • 18
    • 0004078454 scopus 로고    scopus 로고
    • San Diego, CA, United States: Academic Press
    • Brody T. 1999. Nutritional Biochemistry. San Diego, CA, United States: Academic Press. p 332-345.
    • (1999) Nutritional Biochemistry , pp. 332-345
    • Brody, T.1
  • 23
    • 34347400391 scopus 로고    scopus 로고
    • Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation
    • Chambers E, Mitragotri S. 2007. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. Exp Biol Med 232(7):958-966.
    • (2007) Exp Biol Med , vol.232 , Issue.7 , pp. 958-966
    • Chambers, E.1    Mitragotri, S.2
  • 24
    • 9944261933 scopus 로고    scopus 로고
    • Insulin detemir: A review of its use in the management of type 1 and 2 diabetes mellitus
    • Chapman T, Perry C. 2004. Insulin detemir: A review of its use in the management of type 1 and 2 diabetes mellitus. Drugs 64(22):2577-2595.
    • (2004) Drugs , vol.64 , Issue.22 , pp. 2577-2595
    • Chapman, T.1    Perry, C.2
  • 25
    • 0037415556 scopus 로고    scopus 로고
    • The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
    • Chaudhury C, Mehnaz S, Robinson J, Hayton W, Pearl D, Roopenian D, Anderson C. 2003. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197(3):315-322.
    • (2003) J Exp Med , vol.197 , Issue.3 , pp. 315-322
    • Chaudhury, C.1    Mehnaz, S.2    Robinson, J.3    Hayton, W.4    Pearl, D.5    Roopenian, D.6    Anderson, C.7
  • 27
    • 34248597761 scopus 로고    scopus 로고
    • Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo
    • Chen J, Corbin IR, Li H, Cao W, Glickson JD, Zheng G. 2007. Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J Am Chem Soc 129(18):5798-5799.
    • (2007) J Am Chem Soc , vol.129 , Issue.18 , pp. 5798-5799
    • Chen, J.1    Corbin, I.R.2    Li, H.3    Cao, W.4    Glickson, J.D.5    Zheng, G.6
  • 28
    • 85018501567 scopus 로고    scopus 로고
    • Advanced drug delivery in cancer therapy
    • In: Ashim Mitra CHL, Cheng K. Hoboken, New Jersey: JohnWiley & Sons.
    • Cheng W, Tai K. 2013. Advanced drug delivery in cancer therapy. In: Ashim Mitra CHL, Cheng K. Advanced drug delivery. Hoboken, New Jersey: JohnWiley & Sons.
    • (2013) Advanced drug delivery
    • Cheng, W.1    Tai, K.2
  • 31
    • 84881582632 scopus 로고    scopus 로고
    • Ligand-Coupled Lipoprotein for Ovarian Cancer-Specific Drug Delivery
    • In: Malek A, Tchernitsa O. Humana Press
    • Corbin I. 2013. Ligand-Coupled Lipoprotein for Ovarian Cancer-Specific Drug Delivery. In: Malek A, Tchernitsa O. Ovarian Cancer. Humana Press. p 467-480.
    • (2013) Ovarian Cancer , pp. 467-480
    • Corbin, I.1
  • 32
    • 0036553910 scopus 로고    scopus 로고
    • Erythrocytes deliver Tat to interferon-γ-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro
    • Corinti S, Chiarantini L, Dominici S, Laguardia ME, Magnani M, Girolomoni G. 2002. Erythrocytes deliver Tat to interferon-γ-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro. J Leukoc Biol 71(4):652-658.
    • (2002) J Leukoc Biol , vol.71 , Issue.4 , pp. 652-658
    • Corinti, S.1    Chiarantini, L.2    Dominici, S.3    Laguardia, M.E.4    Magnani, M.5    Girolomoni, G.6
  • 34
    • 33644753906 scopus 로고    scopus 로고
    • Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel
    • Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P. 2006. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12(4):1317-1324.
    • (2006) Clin Cancer Res , vol.12 , Issue.4 , pp. 1317-1324
    • Desai, N.1    Trieu, V.2    Yao, Z.3    Louie, L.4    Ci, S.5    Yang, A.6    Tao, C.7    De, T.8    Beals, B.9    Dykes, D.10    Noker, P.11    Yao, R.12    Labao, E.13    Hawkins, M.14    Soon-Shiong, P.15
  • 35
    • 24944506410 scopus 로고    scopus 로고
    • Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy
    • Dierling A, Cui Z. 2005. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. Int J Pharm 303(1-2):143-152.
    • (2005) Int J Pharm , vol.303 , Issue.1-2 , pp. 143-152
    • Dierling, A.1    Cui, Z.2
  • 39
    • 70350187071 scopus 로고    scopus 로고
    • Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system
    • Dosio F, Arpicco S, Stella B, Brusa P, Cattel L. 2009. Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. Int J Pharm 382(1-2):117-123.
    • (2009) Int J Pharm , vol.382 , Issue.1-2 , pp. 117-123
    • Dosio, F.1    Arpicco, S.2    Stella, B.3    Brusa, P.4    Cattel, L.5
  • 40
    • 79952746215 scopus 로고    scopus 로고
    • EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers
    • Dosio F, Milla P, Cattel L. 2010. EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers. Curr Opin Investig Drugs 11(12):1424-1433.
    • (2010) Curr Opin Investig Drugs , vol.11 , Issue.12 , pp. 1424-1433
    • Dosio, F.1    Milla, P.2    Cattel, L.3
  • 43
    • 78650408680 scopus 로고    scopus 로고
    • RGD modified albumin nanospheres for tumour vasculature targeting
    • Dubey P, Singodia D, Verma R, Vyas S. 2011. RGD modified albumin nanospheres for tumour vasculature targeting. J Pharm Pharmacol 63(1):33-40.
    • (2011) J Pharm Pharmacol , vol.63 , Issue.1 , pp. 33-40
    • Dubey, P.1    Singodia, D.2    Verma, R.3    Vyas, S.4
  • 44
    • 0033515598 scopus 로고    scopus 로고
    • Expression and characterization of a DNase I-Fc fusion enzyme
    • Dwyer M, Huang A, Pan C, Lazarus R. 1999. Expression and characterization of a DNase I-Fc fusion enzyme. J Biol Chem 274(14):9738-9743.
    • (1999) J Biol Chem , vol.274 , Issue.14 , pp. 9738-9743
    • Dwyer, M.1    Huang, A.2    Pan, C.3    Lazarus, R.4
  • 46
    • 0022553643 scopus 로고
    • In vivo clearance of antibody-sensitized human drug carrier erythrocytes
    • Eichler HG, Gasic S, Bauer K, Korn A, Bacher S. 1986. In vivo clearance of antibody-sensitized human drug carrier erythrocytes. Clin Pharmacol Ther 40(3):300-303.
    • (1986) Clin Pharmacol Ther , vol.40 , Issue.3 , pp. 300-303
    • Eichler, H.G.1    Gasic, S.2    Bauer, K.3    Korn, A.4    Bacher, S.5
  • 48
    • 84861526023 scopus 로고    scopus 로고
    • Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163
    • Etzerodt A, Maniecki MB, Graversen JH, Møller HJ, Torchilin VP, Moestrup SK. 2012. Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. J Control Release 160(1):72-80.
    • (2012) J Control Release , vol.160 , Issue.1 , pp. 72-80
    • Etzerodt, A.1    Maniecki, M.B.2    Graversen, J.H.3    Møller, H.J.4    Torchilin, V.P.5    Moestrup, S.K.6
  • 50
    • 0027022186 scopus 로고
    • Targeting of tumor cells by low density lipoproteins: Principle and use of ellipticin derivatives
    • Favre G. 1992. Targeting of tumor cells by low density lipoproteins: Principle and use of ellipticin derivatives. C R Seances Soc Biol Fil 186(1-2):73-87.
    • (1992) C R Seances Soc Biol Fil , vol.186 , Issue.1-2 , pp. 73-87
    • Favre, G.1
  • 51
    • 47949115836 scopus 로고    scopus 로고
    • Targeted drug delivery by in vivo coupling to endogenous albumin: An albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis
    • Fiehn C, Kratz F, Sass G, Müller-Ladner U, Neumann E. 2008. Targeted drug delivery by in vivo coupling to endogenous albumin: An albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheum Dis 67(8):1188-1191.
    • (2008) Ann Rheum Dis , vol.67 , Issue.8 , pp. 1188-1191
    • Fiehn, C.1    Kratz, F.2    Sass, G.3    Müller-Ladner, U.4    Neumann, E.5
  • 52
    • 0028386492 scopus 로고
    • Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells
    • Firestone RA. 1994. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem 5(2):105-113.
    • (1994) Bioconjug Chem , vol.5 , Issue.2 , pp. 105-113
    • Firestone, R.A.1
  • 54
    • 10644250277 scopus 로고    scopus 로고
    • SPARC and tumor growth: Where the seed meets the soil
    • Framson P, Sage E. 2004. SPARC and tumor growth: Where the seed meets the soil? J Cell Biochem 92(4):679-690.
    • (2004) J Cell Biochem , vol.92 , Issue.4 , pp. 679-690
    • Framson, P.1    Sage, E.2
  • 55
    • 0036888324 scopus 로고    scopus 로고
    • Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model
    • Fraternale A, Casabianca A, Orlandi C, Cerasi A, Chiarantini L, Brandi G, Magnani M. 2002. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. Antiviral Res 56(3):263-272.
    • (2002) Antiviral Res , vol.56 , Issue.3 , pp. 263-272
    • Fraternale, A.1    Casabianca, A.2    Orlandi, C.3    Cerasi, A.4    Chiarantini, L.5    Brandi, G.6    Magnani, M.7
  • 56
    • 70350776969 scopus 로고    scopus 로고
    • Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery
    • Fu Q, Sun J, Zhang W, Sui X, Yan Z, He Z. 2009. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov 4(3):262-272.
    • (2009) Recent Pat Anticancer Drug Discov , vol.4 , Issue.3 , pp. 262-272
    • Fu, Q.1    Sun, J.2    Zhang, W.3    Sui, X.4    Yan, Z.5    He, Z.6
  • 58
    • 33745458519 scopus 로고    scopus 로고
    • Albumin-bound paclitaxel: A next-generation taxane
    • Gradishar W. 2006. Albumin-bound paclitaxel: A next-generation taxane. Expert Opin Pharmacother 7(8):1041-1053.
    • (2006) Expert Opin Pharmacother , vol.7 , Issue.8 , pp. 1041-1053
    • Gradishar, W.1
  • 59
    • 34447301770 scopus 로고    scopus 로고
    • Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain
    • Gupta Y, Jain A, Jain SK. 2007. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 59(7):935-940.
    • (2007) J Pharm Pharmacol , vol.59 , Issue.7 , pp. 935-940
    • Gupta, Y.1    Jain, A.2    Jain, S.K.3
  • 61
    • 0037390497 scopus 로고    scopus 로고
    • Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system
    • Hammel M, Laggner P, Prassl R. 2003. Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system. Chem Phys Lipids 123(2):193-207.
    • (2003) Chem Phys Lipids , vol.123 , Issue.2 , pp. 193-207
    • Hammel, M.1    Laggner, P.2    Prassl, R.3
  • 62
    • 0032822827 scopus 로고    scopus 로고
    • Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier
    • Han J-H, Oh Y-K, Kim D-S, Kim C-K. 1999. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier. Int J Pharm 188(1):39-47.
    • (1999) Int J Pharm , vol.188 , Issue.1 , pp. 39-47
    • Han, J.-H.1    Oh, Y.-K.2    Kim, D.-S.3    Kim, C.-K.4
  • 65
    • 33745829014 scopus 로고    scopus 로고
    • The leak stops here: Platelets as delivery vehicles for coagulation factors
    • High K. 2006. The leak stops here: Platelets as delivery vehicles for coagulation factors. J Clin Invest 116(7):1840-1842.
    • (2006) J Clin Invest , vol.116 , Issue.7 , pp. 1840-1842
    • High, K.1
  • 66
    • 44949160947 scopus 로고    scopus 로고
    • Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
    • Hodson L, Skeaff C, Fielding B. 2008. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47(5):348-380.
    • (2008) Prog Lipid Res , vol.47 , Issue.5 , pp. 348-380
    • Hodson, L.1    Skeaff, C.2    Fielding, B.3
  • 67
    • 49449094179 scopus 로고    scopus 로고
    • Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
    • Hoffman H, Throne M, Amar N, Sebai M, Kivitz A, Kavanaugh A, Weinstein S, Belomestnov P, Yancopoulos G, Stahl N, Mellis S. 2008. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies. Arthritis Rheum 58(8):2443-2452.
    • (2008) Arthritis Rheum , vol.58 , Issue.8 , pp. 2443-2452
    • Hoffman, H.1    Throne, M.2    Amar, N.3    Sebai, M.4    Kivitz, A.5    Kavanaugh, A.6    Weinstein, S.7    Belomestnov, P.8    Yancopoulos, G.9    Stahl, N.10    Mellis, S.11
  • 68
    • 77951188983 scopus 로고    scopus 로고
    • Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery
    • Holden CA, Yuan Q, Yeudall WA, Lebman DA, Yan H. 2010. Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery. Int J Nanomedicine 5:25-36.
    • (2010) Int J Nanomedicine , vol.5 , pp. 25-36
    • Holden, C.A.1    Yuan, Q.2    Yeudall, W.A.3    Lebman, D.A.4    Yan, H.5
  • 69
    • 34250803927 scopus 로고    scopus 로고
    • Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome
    • Hsieh W-C, Chang Y, Hsu M-C, Lan B-S, Hsiao G-C, Chuang H-C, Su I-J. 2007. Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome. Am J Pathol 170(5):1629-1639.
    • (2007) Am J Pathol , vol.170 , Issue.5 , pp. 1629-1639
    • Hsieh, W.-C.1    Chang, Y.2    Hsu, M.-C.3    Lan, B.-S.4    Hsiao, G.-C.5    Chuang, H.-C.6    Su, I.-J.7
  • 70
    • 0029123596 scopus 로고
    • A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity
    • Ippoliti R, Lendaro E, D'Agostino I, Fiani M, Guidarini D, Vestri S, Benedetti P, Brunori M. 1995. A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity. FASEB J 9(12):1220-1225.
    • (1995) FASEB J , vol.9 , Issue.12 , pp. 1220-1225
    • Ippoliti, R.1    Lendaro, E.2    D'Agostino, I.3    Fiani, M.4    Guidarini, D.5    Vestri, S.6    Benedetti, P.7    Brunori, M.8
  • 71
    • 0043028168 scopus 로고    scopus 로고
    • RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting
    • Jain S, Mishra V, Singh P, Dubey PK, Saraf DK, Vyas SP. 2003. RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int J Pharm 261(1-2):43-55.
    • (2003) Int J Pharm , vol.261 , Issue.1-2 , pp. 43-55
    • Jain, S.1    Mishra, V.2    Singh, P.3    Dubey, P.K.4    Saraf, D.K.5    Vyas, S.P.6
  • 73
    • 0018537813 scopus 로고
    • The important of surface area/volume ratio to the rate of oxygen uptake by red cells
    • Jones D. 1979. The important of surface area/volume ratio to the rate of oxygen uptake by red cells. J Gen Physiol 74(5):643-646.
    • (1979) J Gen Physiol , vol.74 , Issue.5 , pp. 643-646
    • Jones, D.1
  • 74
    • 0031011598 scopus 로고    scopus 로고
    • In vitro properties and organ uptake of rat band 3 cross-linked erythrocytes
    • Jordan J, Murciano J, Lotero A, Herraez A, Diez J. 1997. In vitro properties and organ uptake of rat band 3 cross-linked erythrocytes. Biochimie 79(1):53-61.
    • (1997) Biochimie , vol.79 , Issue.1 , pp. 53-61
    • Jordan, J.1    Murciano, J.2    Lotero, A.3    Herraez, A.4    Diez, J.5
  • 75
    • 67649472398 scopus 로고    scopus 로고
    • Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
    • José B, Sandra MS. 2009. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9(7):463-475.
    • (2009) Nat Rev Cancer , vol.9 , Issue.7 , pp. 463-475
    • José, B.1    Sandra, M.S.2
  • 76
    • 0037161335 scopus 로고    scopus 로고
    • Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells
    • Kader A, Pater A. 2002. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells. J Control Release 80(1-3):29-44.
    • (2002) J Control Release , vol.80 , Issue.1-3 , pp. 29-44
    • Kader, A.1    Pater, A.2
  • 77
    • 63449105836 scopus 로고    scopus 로고
    • Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes
    • Kapur S, Bonk M. 2009. Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes. P T 34(3):138-141.
    • (2009) P T , vol.34 , Issue.3 , pp. 138-141
    • Kapur, S.1    Bonk, M.2
  • 79
    • 33646255225 scopus 로고    scopus 로고
    • Polymer-drug conjugates: Progress in polymeric prodrugs
    • Khandare J, Minko T. 2006. Polymer-drug conjugates: Progress in polymeric prodrugs. Progress in Polymer Science 31(4):359-397.
    • (2006) Progress in Polymer Science , vol.31 , Issue.4 , pp. 359-397
    • Khandare, J.1    Minko, T.2
  • 80
    • 78649928659 scopus 로고    scopus 로고
    • Improving protein pharmacokinetics by engineering erythrocyte affinity
    • Kontos S, Hubbell J. 2010. Improving protein pharmacokinetics by engineering erythrocyte affinity. Mol Pharm 7(6):2141-2147.
    • (2010) Mol Pharm , vol.7 , Issue.6 , pp. 2141-2147
    • Kontos, S.1    Hubbell, J.2
  • 81
    • 79953847826 scopus 로고    scopus 로고
    • INNO-206 (DOXO-EMCH), an albumin-binding prodrug of doxorubicin under development for phase II studies
    • Kratz F. 2011. INNO-206 (DOXO-EMCH), an albumin-binding prodrug of doxorubicin under development for phase II studies. Curr Bioact Compd 7(1):33-38.
    • (2011) Curr Bioact Compd , vol.7 , Issue.1 , pp. 33-38
    • Kratz, F.1
  • 82
    • 0037028050 scopus 로고    scopus 로고
    • Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound
    • Kratz F, Warnecke A, Scheuermann K, Stockmar C, Schwab J, Lazar P, Druckes P, Esser N, Drevs J, Rognan D, Bissantz C, Hinderling C, Folkers G, Fichtner I, Unger C. 2002. Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J Med Chem 45(25):5523-5533.
    • (2002) J Med Chem , vol.45 , Issue.25 , pp. 5523-5533
    • Kratz, F.1    Warnecke, A.2    Scheuermann, K.3    Stockmar, C.4    Schwab, J.5    Lazar, P.6    Druckes, P.7    Esser, N.8    Drevs, J.9    Rognan, D.10    Bissantz, C.11    Hinderling, C.12    Folkers, G.13    Fichtner, I.14    Unger, C.15
  • 84
    • 85007107552 scopus 로고    scopus 로고
    • Future prospectus in targetting drug delivery: A review on resealed erytrocytes-A promising carrier scholars
    • Krishnaveni G, Krishnamoorthy B, Muthukumaran M. 2013. Future prospectus in targetting drug delivery: A review on resealed erytrocytes-A promising carrier scholars. Acad J Pharm 2(2):81-88.
    • (2013) Acad J Pharm , vol.2 , Issue.2 , pp. 81-88
    • Krishnaveni, G.1    Krishnamoorthy, B.2    Muthukumaran, M.3
  • 85
    • 77958524856 scopus 로고    scopus 로고
    • Novel anti-tn single-chain Fv-Fc fusion proteins derived from immunized phage library and antibody Fc domain
    • Kubota T, Matsushita T, Niwa R, Kumagai I, Nakamura K. 2010. Novel anti-tn single-chain Fv-Fc fusion proteins derived from immunized phage library and antibody Fc domain. Anticancer Res 30(9):3397-3405.
    • (2010) Anticancer Res , vol.30 , Issue.9 , pp. 3397-3405
    • Kubota, T.1    Matsushita, T.2    Niwa, R.3    Kumagai, I.4    Nakamura, K.5
  • 86
    • 33845975658 scopus 로고    scopus 로고
    • Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice
    • Kumar M, Hunag Y, Glinka Y, Prud'homme GJ, Wang Q. 2007. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice. Gene Ther 14(2):162-172.
    • (2007) Gene Ther , vol.14 , Issue.2 , pp. 162-172
    • Kumar, M.1    Hunag, Y.2    Glinka, Y.3    Prud'homme, G.J.4    Wang, Q.5
  • 89
    • 71949100459 scopus 로고    scopus 로고
    • Artemisinin-transferrin conjugate retards growth of breast tumors in the rat
    • Lai H, Nakase I, Lacoste E, Singh N, Sasaki T. 2009. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat. Anticancer Res 29(10):3807-3810.
    • (2009) Anticancer Res , vol.29 , Issue.10 , pp. 3807-3810
    • Lai, H.1    Nakase, I.2    Lacoste, E.3    Singh, N.4    Sasaki, T.5
  • 90
    • 11844269839 scopus 로고    scopus 로고
    • Effects of artemisinin-tagged holotransferrin on cancer cells
    • Lai H, Sasaki T, Singh N, Messay A. 2005. Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci 76(11):1267-1279.
    • (2005) Life Sci , vol.76 , Issue.11 , pp. 1267-1279
    • Lai, H.1    Sasaki, T.2    Singh, N.3    Messay, A.4
  • 91
    • 0031451777 scopus 로고    scopus 로고
    • Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
    • Laske D, Youle R, Oldfield E. 1997. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3(12):1362-1368.
    • (1997) Nat Med , vol.3 , Issue.12 , pp. 1362-1368
    • Laske, D.1    Youle, R.2    Oldfield, E.3
  • 94
    • 34247158645 scopus 로고    scopus 로고
    • Expression and characterization of human growth hormone-Fc fusion proteins for transcytosis induction
    • Lee C, Woo J, Cho K, Kang S, Kang S, Choi Y. 2007. Expression and characterization of human growth hormone-Fc fusion proteins for transcytosis induction. Biotechnol Appl Biochem 46(Pt 4):211-217.
    • (2007) Biotechnol Appl Biochem , vol.46 , Issue.PART. 4 , pp. 211-217
    • Lee, C.1    Woo, J.2    Cho, K.3    Kang, S.4    Kang, S.5    Choi, Y.6
  • 96
    • 24044461733 scopus 로고    scopus 로고
    • Macrophage responses to hypoxia: Implications for tumor progression and anti-cancer therapies
    • Lewis C, Murdoch C. 2005. Macrophage responses to hypoxia: Implications for tumor progression and anti-cancer therapies. Am J Pathol 167(3):627-635.
    • (2005) Am J Pathol , vol.167 , Issue.3 , pp. 627-635
    • Lewis, C.1    Murdoch, C.2
  • 97
    • 84862790727 scopus 로고    scopus 로고
    • A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas
    • Li Y, He H, Jia X, Lu W-L, Lou J, Wei Y. 2012. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 33(15):3899-3908.
    • (2012) Biomaterials , vol.33 , Issue.15 , pp. 3899-3908
    • Li, Y.1    He, H.2    Jia, X.3    Lu, W.-L.4    Lou, J.5    Wei, Y.6
  • 98
    • 84886963876 scopus 로고    scopus 로고
    • Lipids: Absorption and Transport
    • In: Erdman J, MacDonald I, Zeisel S. Oxford, UK: Wiley-Blackwell.
    • Lichtenstein AH, Jones PJH. 2012. Lipids: Absorption and Transport. In: Erdman J, MacDonald I, Zeisel S. Present Knowledge in Nutrition. Oxford, UK: Wiley-Blackwell. p 118-131.
    • (2012) Present Knowledge in Nutrition , pp. 118-131
    • Lichtenstein, A.H.1    Jones, P.J.H.2
  • 99
    • 45749083773 scopus 로고    scopus 로고
    • Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
    • Liong M, Lu J, Kovochich M, Xia T, Ruehm S, Nel A, Tamanoi F, Zink J. 2008. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5):889-896.
    • (2008) ACS Nano , vol.2 , Issue.5 , pp. 889-896
    • Liong, M.1    Lu, J.2    Kovochich, M.3    Xia, T.4    Ruehm, S.5    Nel, A.6    Tamanoi, F.7    Zink, J.8
  • 100
    • 13444250281 scopus 로고    scopus 로고
    • San Diego, CA, United States: Elsevier Academic Press.
    • Litwack G. 2008. Folic acid and folates. San Diego, CA, United States: Elsevier Academic Press.
    • (2008) Folic acid and folates
    • Litwack, G.1
  • 101
    • 84967546704 scopus 로고    scopus 로고
    • Lipoproteins as pharmaceutical carriers
    • In: Torchilin V. London, UK: Imperial College Press
    • Liu S, Wang S, Lu R. 2006. Lipoproteins as pharmaceutical carriers. In: Torchilin V. Nanoparticulates as drug carriers. London, UK: Imperial College Press. p 173-186.
    • (2006) Nanoparticulates as drug carriers , pp. 173-186
    • Liu, S.1    Wang, S.2    Lu, R.3
  • 102
    • 0037451745 scopus 로고    scopus 로고
    • Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells
    • Lotero L, Olmos G, Diez J. 2003. Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells. Biochim Biophys Acta 1620(1-3):160-166.
    • (2003) Biochim Biophys Acta , vol.1620 , Issue.1-3 , pp. 160-166
    • Lotero, L.1    Olmos, G.2    Diez, J.3
  • 103
    • 85007107314 scopus 로고    scopus 로고
    • Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility
    • Low SC. 2005. Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility. Google Patents.
    • (2005) Google Patents
    • Low, S.C.1
  • 104
    • 58949093276 scopus 로고    scopus 로고
    • Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
    • Lubgan D, Jozwiak Z, Grabenbauer G, Distel L. 2009. Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells. Cell Mol Biol Lett 14(1):113-127.
    • (2009) Cell Mol Biol Lett , vol.14 , Issue.1 , pp. 113-127
    • Lubgan, D.1    Jozwiak, Z.2    Grabenbauer, G.3    Distel, L.4
  • 105
    • 42449138655 scopus 로고    scopus 로고
    • Curbing the appetites of the big eaters
    • Luft F. 2008. Curbing the appetites of the big eaters. J Mol Med 86(4):351-352.
    • (2008) J Mol Med , vol.86 , Issue.4 , pp. 351-352
    • Luft, F.1
  • 106
    • 84870391160 scopus 로고    scopus 로고
    • Transferrin-cisplatin specifically deliver cisplatin to HepG2 cells in vitro and enhance cisplatin cytotoxicity
    • Luo L-Z, Jin H-W, Huang H-Q. 2012a. Transferrin-cisplatin specifically deliver cisplatin to HepG2 cells in vitro and enhance cisplatin cytotoxicity. J Proteomics 77:237-250.
    • (2012) J Proteomics , vol.77 , pp. 237-250
    • Luo, L.-Z.1    Jin, H.-W.2    Huang, H.-Q.3
  • 107
    • 84857633697 scopus 로고    scopus 로고
    • Engineering of erythrocyte-based drug carriers: Control of protein release and bioactivity
    • Luo R, Mutukumaraswamy S, Venkatraman S, Neu B. 2012b. Engineering of erythrocyte-based drug carriers: Control of protein release and bioactivity. J Mater Sci Mater Med 23(1):63-71.
    • (2012) J Mater Sci Mater Med , vol.23 , Issue.1 , pp. 63-71
    • Luo, R.1    Mutukumaraswamy, S.2    Venkatraman, S.3    Neu, B.4
  • 108
    • 77954926895 scopus 로고    scopus 로고
    • Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery
    • MacEwan S, Callahan D, Chilkoti A. 2010. Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine (Lond) 5(5):793-806.
    • (2010) Nanomedicine (Lond) , vol.5 , Issue.5 , pp. 793-806
    • MacEwan, S.1    Callahan, D.2    Chilkoti, A.3
  • 112
    • 0026770371 scopus 로고
    • Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies
    • Magnani M, Rossi L, Brandi G, Schiavano GF, Montroni M, Piedimonte G. 1992b. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies. Proc Natl Acad Sci 89(14):6477-6481.
    • (1992) Proc Natl Acad Sci , vol.89 , Issue.14 , pp. 6477-6481
    • Magnani, M.1    Rossi, L.2    Brandi, G.3    Schiavano, G.F.4    Montroni, M.5    Piedimonte, G.6
  • 114
    • 77954634088 scopus 로고    scopus 로고
    • Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer
    • Matsui M, Shimizu Y, Kodera Y, Kondo E, Ikehara Y, Nakanishi H. 2010. Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. Cancer Sci 101(7):1670-1677.
    • (2010) Cancer Sci , vol.101 , Issue.7 , pp. 1670-1677
    • Matsui, M.1    Shimizu, Y.2    Kodera, Y.3    Kondo, E.4    Ikehara, Y.5    Nakanishi, H.6
  • 115
    • 0022858683 scopus 로고
    • A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
    • Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387-6392.
    • (1986) Cancer Res , vol.46 , Issue.12 PART. 1 , pp. 6387-6392
    • Matsumura, Y.1    Maeda, H.2
  • 116
    • 0021365844 scopus 로고
    • Potential role of platelets in the pathogenesis of tumor metastasis
    • Mehta P. 1984. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 63(1):55-63.
    • (1984) Blood , vol.63 , Issue.1 , pp. 55-63
    • Mehta, P.1
  • 117
    • 77949275122 scopus 로고    scopus 로고
    • Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications
    • Menjoge A, Kannan R, Tomalia D. 2010. Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications. Drug Discov Today 15(5-6):171-185.
    • (2010) Drug Discov Today , vol.15 , Issue.5-6 , pp. 171-185
    • Menjoge, A.1    Kannan, R.2    Tomalia, D.3
  • 119
    • 84858333416 scopus 로고    scopus 로고
    • Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates
    • Millington T, Koulmanda M, Ng C, Boskovic S, Nadazdin O, Benichou G, Zheng X, Strom T, Madsen J. 2012. Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates. J Heart Lung Transplant 31(4):427-435.
    • (2012) J Heart Lung Transplant , vol.31 , Issue.4 , pp. 427-435
    • Millington, T.1    Koulmanda, M.2    Ng, C.3    Boskovic, S.4    Nadazdin, O.5    Benichou, G.6    Zheng, X.7    Strom, T.8    Madsen, J.9
  • 120
    • 0033638014 scopus 로고    scopus 로고
    • Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake
    • Mishra PR, Jain NK. 2000. Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake. J Drug Target 8(4):217-224.
    • (2000) J Drug Target , vol.8 , Issue.4 , pp. 217-224
    • Mishra, P.R.1    Jain, N.K.2
  • 121
    • 77954512738 scopus 로고    scopus 로고
    • Proteomics retrenches
    • Mitchell P. 2010. Proteomics retrenches. Nat Biotechnol 28(7):665-670.
    • (2010) Nat Biotechnol , vol.28 , Issue.7 , pp. 665-670
    • Mitchell, P.1
  • 124
    • 34250311499 scopus 로고    scopus 로고
    • Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme
    • Nikanjam M, Blakely E, Bjornstad K, Shu X, Budinger T, Forte T. 2007. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme. Int J Pharm 328(1):86-94.
    • (2007) Int J Pharm , vol.328 , Issue.1 , pp. 86-94
    • Nikanjam, M.1    Blakely, E.2    Bjornstad, K.3    Shu, X.4    Budinger, T.5    Forte, T.6
  • 125
    • 0026575708 scopus 로고
    • Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes
    • Ninfali P, Rossi L, Baronciani L, Tirillini B, Ropars C, Magnani M. 1992. Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes. Alcohol Alcohol 27(1):19-23.
    • (1992) Alcohol Alcohol , vol.27 , Issue.1 , pp. 19-23
    • Ninfali, P.1    Rossi, L.2    Baronciani, L.3    Tirillini, B.4    Ropars, C.5    Magnani, M.6
  • 126
    • 84905060986 scopus 로고    scopus 로고
    • Celtic Pharma Terminates Transmid Trial KSB311R/CIII/001.
    • Noonan M. 2007. Celtic Pharma Terminates Transmid Trial KSB311R/CIII/001.
    • (2007)
    • Noonan, M.1
  • 127
    • 57749092893 scopus 로고    scopus 로고
    • Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide
    • Oh S, Kim B, Singh N, Lai H, Sasaki T. 2009. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Cancer Lett 274(1):33-39.
    • (2009) Cancer Lett , vol.274 , Issue.1 , pp. 33-39
    • Oh, S.1    Kim, B.2    Singh, N.3    Lai, H.4    Sasaki, T.5
  • 128
    • 14644392093 scopus 로고    scopus 로고
    • Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
    • Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. 2005. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338(2):284-293.
    • (2005) Anal Biochem , vol.338 , Issue.2 , pp. 284-293
    • Parker, N.1    Turk, M.J.2    Westrick, E.3    Lewis, J.D.4    Low, P.S.5    Leamon, C.P.6
  • 129
    • 1942503257 scopus 로고    scopus 로고
    • Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis
    • Paulos CM, Turk MJ, Breur GJ, Low PS. 2004. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 56(8):1205-1217.
    • (2004) Adv Drug Deliv Rev , vol.56 , Issue.8 , pp. 1205-1217
    • Paulos, C.M.1    Turk, M.J.2    Breur, G.J.3    Low, P.S.4
  • 130
    • 0025827590 scopus 로고
    • A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity
    • Peppel K, Crawford D, Beutler B. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174(6):1483-1489.
    • (1991) J Exp Med , vol.174 , Issue.6 , pp. 1483-1489
    • Peppel, K.1    Crawford, D.2    Beutler, B.3
  • 131
    • 84873043409 scopus 로고    scopus 로고
    • Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
    • Peters R, Toby G, Lu Q, Liu T, Kulman J, Low S, Bitonti A, Pierce G. 2013. Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein. J Thromb Haemost 11(1):132-141.
    • (2013) J Thromb Haemost , vol.11 , Issue.1 , pp. 132-141
    • Peters, R.1    Toby, G.2    Lu, Q.3    Liu, T.4    Kulman, J.5    Low, S.6    Bitonti, A.7    Pierce, G.8
  • 133
    • 84934434290 scopus 로고    scopus 로고
    • Engineering peptide therapeutics using MIMETIBODY™ technology
    • Picha K, Huang C, Bugelski P, O'Neil K. 2014. Engineering peptide therapeutics using MIMETIBODY™ technology. Methods Mol Biol 1088:125-145.
    • (2014) Methods Mol Biol , vol.1088 , pp. 125-145
    • Picha, K.1    Huang, C.2    Bugelski, P.3    O'Neil, K.4
  • 134
    • 0021061849 scopus 로고
    • Encapsulation of drugs in intact erythrocytes: An intravenous delivery system
    • Pitt E, Johnson CM, Lewis DA, Jenner DA, Offord RE. 1983. Encapsulation of drugs in intact erythrocytes: An intravenous delivery system. Biochem Pharmacol 32(22):3359-3368.
    • (1983) Biochem Pharmacol , vol.32 , Issue.22 , pp. 3359-3368
    • Pitt, E.1    Johnson, C.M.2    Lewis, D.A.3    Jenner, D.A.4    Offord, R.E.5
  • 137
    • 79955481749 scopus 로고    scopus 로고
    • Exosomes as intercellular signalosomes and pharmacological effectors
    • Record M, Subra C, Silvente-Poirot S, Poirot M. 2011. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81(10):1171-1182.
    • (2011) Biochem Pharmacol , vol.81 , Issue.10 , pp. 1171-1182
    • Record, M.1    Subra, C.2    Silvente-Poirot, S.3    Poirot, M.4
  • 140
    • 84993913350 scopus 로고
    • Selective liver targeting of antivirals by recombinant chylomicrons-A new therapeutic approach to hepatitis B
    • Rensen P, van Dijk M, Havenaar E, Bijsterbosch M, Kruijt J, van Berkel T. 1995. Selective liver targeting of antivirals by recombinant chylomicrons-A new therapeutic approach to hepatitis B. Nat Med 1(3):221-225.
    • (1995) Nat Med , vol.1 , Issue.3 , pp. 221-225
    • Rensen, P.1    van Dijk, M.2    Havenaar, E.3    Bijsterbosch, M.4    Kruijt, J.5    van Berkel, T.6
  • 141
    • 67349137868 scopus 로고    scopus 로고
    • Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
    • Richardson D, Kalinowski D, Lau S, Jansson P, Lovejoy D. 2009. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 1790(7):702-717.
    • (2009) Biochim Biophys Acta , vol.1790 , Issue.7 , pp. 702-717
    • Richardson, D.1    Kalinowski, D.2    Lau, S.3    Jansson, P.4    Lovejoy, D.5
  • 144
    • 34548229364 scopus 로고    scopus 로고
    • FcRn: The neonatal Fc receptor comes of age
    • Roopenian D, Akilesh S. 2007. FcRn: The neonatal Fc receptor comes of age. Nat Rev Immunol 7(9):715-725.
    • (2007) Nat Rev Immunol , vol.7 , Issue.9 , pp. 715-725
    • Roopenian, D.1    Akilesh, S.2
  • 146
    • 73349127491 scopus 로고    scopus 로고
    • Liraglutide in type 2 diabetes: From pharmacological development to clinical practice
    • Rossi M, Nicolucci A. 2009. Liraglutide in type 2 diabetes: From pharmacological development to clinical practice. Acta Biomed 80(2):93-101.
    • (2009) Acta Biomed , vol.80 , Issue.2 , pp. 93-101
    • Rossi, M.1    Nicolucci, A.2
  • 150
    • 84886087036 scopus 로고    scopus 로고
    • Drug delivery using platelet cancer cell interaction
    • Sarkar S, Alam MA, Shaw J, Dasgupta AK. 2013. Drug delivery using platelet cancer cell interaction. Pharm Res 30(11):2785-2794.
    • (2013) Pharm Res , vol.30 , Issue.11 , pp. 2785-2794
    • Sarkar, S.1    Alam, M.A.2    Shaw, J.3    Dasgupta, A.K.4
  • 152
    • 44149103399 scopus 로고    scopus 로고
    • Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker
    • Satyam A. 2008. Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker. Bioorg Med Chem Lett 18(11):3196-3199.
    • (2008) Bioorg Med Chem Lett , vol.18 , Issue.11 , pp. 3196-3199
    • Satyam, A.1
  • 153
    • 0023274371 scopus 로고
    • Secretion of human serum albumin from Bacillus subtilis
    • Saunders C, Schmidt B, Mallonee R, Guyer M. 1987. Secretion of human serum albumin from Bacillus subtilis. J Bacteriol 169(7):2917-2925.
    • (1987) J Bacteriol , vol.169 , Issue.7 , pp. 2917-2925
    • Saunders, C.1    Schmidt, B.2    Mallonee, R.3    Guyer, M.4
  • 154
    • 0026608797 scopus 로고
    • gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis
    • Schnitzer J. 1992. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol 262(1 Pt 2):54.
    • (1992) Am J Physiol , vol.262 , Issue.1 PART. 2 , pp. 54
    • Schnitzer, J.1
  • 155
    • 1842789675 scopus 로고    scopus 로고
    • Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins
    • Seki J, Sonoke S, Saheki A, Koike T, Fukui H, Doi M, Mayumi T. 2004. Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins. Int J Pharm 275(1-2):239-248.
    • (2004) Int J Pharm , vol.275 , Issue.1-2 , pp. 239-248
    • Seki, J.1    Sonoke, S.2    Saheki, A.3    Koike, T.4    Fukui, H.5    Doi, M.6    Mayumi, T.7
  • 159
    • 0036282757 scopus 로고    scopus 로고
    • VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting
    • Shawer M, Greenspan P, Øie S, Lu DR. 2002. VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting. J Pharm Sci 91(6):1405-1413.
    • (2002) J Pharm Sci , vol.91 , Issue.6 , pp. 1405-1413
    • Shawer, M.1    Greenspan, P.2    Øie, S.3    Lu, D.R.4
  • 161
    • 13244262627 scopus 로고    scopus 로고
    • Targeting platelet GPIbalpha transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbbeta and GPIX
    • Shi Q, Wilcox D, Morateck P, Fahs S, Kenny D, Montgomery R. 2004. Targeting platelet GPIbalpha transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbbeta and GPIX. J Thromb Haemost 2(11):1989-1997.
    • (2004) J Thromb Haemost , vol.2 , Issue.11 , pp. 1989-1997
    • Shi, Q.1    Wilcox, D.2    Morateck, P.3    Fahs, S.4    Kenny, D.5    Montgomery, R.6
  • 162
    • 84866565943 scopus 로고    scopus 로고
    • Peptibodies: A flexible alternative format to antibodies
    • Shimamoto G, Gegg C, Boone T, Quéva C. 2012. Peptibodies: A flexible alternative format to antibodies. mAbs 4(5):586-591.
    • (2012) mAbs , vol.4 , Issue.5 , pp. 586-591
    • Shimamoto, G.1    Gegg, C.2    Boone, T.3    Quéva, C.4
  • 164
    • 11944261204 scopus 로고
    • The secretion of human serum albumin from the yeast Saccharomyces cerevisiae using five different leader sequences
    • Sleep D, Belfield G, Goodey A. 1990. The secretion of human serum albumin from the yeast Saccharomyces cerevisiae using five different leader sequences. Bio/technology (Nature Publishing Company) 8(1):42-46.
    • (1990) Bio/technology (Nature Publishing Company) , vol.8 , Issue.1 , pp. 42-46
    • Sleep, D.1    Belfield, G.2    Goodey, A.3
  • 165
    • 84885370061 scopus 로고    scopus 로고
    • Albumin as a versatile platform for drug half-life extension
    • Sleep D, Cameron J, Evans L. 2013. Albumin as a versatile platform for drug half-life extension. Biochim Biophys Acta 1830(12):5526-5534.
    • (2013) Biochim Biophys Acta , vol.1830 , Issue.12 , pp. 5526-5534
    • Sleep, D.1    Cameron, J.2    Evans, L.3
  • 166
    • 38049090659 scopus 로고    scopus 로고
    • Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain
    • Soni V, Kohli DV, Jain SK. 2008. Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain. J Drug Target 16(1):73-78.
    • (2008) J Drug Target , vol.16 , Issue.1 , pp. 73-78
    • Soni, V.1    Kohli, D.V.2    Jain, S.K.3
  • 167
    • 0035083954 scopus 로고    scopus 로고
    • Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin C conjugate in the HepG2 cell and primary cultured rat hepatocyte
    • Tanaka T, Fujishima Y, Kaneo Y. 2001. Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin C conjugate in the HepG2 cell and primary cultured rat hepatocyte. Biol Pharm Bull 24(3):268-273.
    • (2001) Biol Pharm Bull , vol.24 , Issue.3 , pp. 268-273
    • Tanaka, T.1    Fujishima, Y.2    Kaneo, Y.3
  • 168
    • 33751204171 scopus 로고    scopus 로고
    • Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium
    • Temming K, Lacombe M, Schaapveld R, Orfi L, Kéri G, Poelstra K, Molema G, Kok R. 2006. Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium. Chem Med Chem 1(11):1200-1203.
    • (2006) Chem Med Chem , vol.1 , Issue.11 , pp. 1200-1203
    • Temming, K.1    Lacombe, M.2    Schaapveld, R.3    Orfi, L.4    Kéri, G.5    Poelstra, K.6    Molema, G.7    Kok, R.8
  • 170
    • 84874874434 scopus 로고    scopus 로고
    • Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
    • Thomas M, Mousa S, Mousa S. 2013. Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration. Clin Ophthalmol 7:495-501.
    • (2013) Clin Ophthalmol , vol.7 , pp. 495-501
    • Thomas, M.1    Mousa, S.2    Mousa, S.3
  • 172
    • 84869841559 scopus 로고    scopus 로고
    • Comparison of two flow-based imaging methods to measure individual red blood cell area and volume
    • Tomaiuolo G, Rossi D, Caserta S, Cesarelli M, Guido S. 2012. Comparison of two flow-based imaging methods to measure individual red blood cell area and volume. Cytometry A 81(12):1040-1047.
    • (2012) Cytometry A , vol.81 , Issue.12 , pp. 1040-1047
    • Tomaiuolo, G.1    Rossi, D.2    Caserta, S.3    Cesarelli, M.4    Guido, S.5
  • 173
    • 0019874126 scopus 로고
    • Exfoliation of membrane ecto-enzymes in the form of micro-vesicles
    • Trams E, Lauter C, Salem N, Heine U. 1981. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 645(1):63-70.
    • (1981) Biochim Biophys Acta , vol.645 , Issue.1 , pp. 63-70
    • Trams, E.1    Lauter, C.2    Salem, N.3    Heine, U.4
  • 174
    • 84879147391 scopus 로고    scopus 로고
    • Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery
    • Tsuji T, Yoshitomi H, Usukura J. 2013. Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery. Microscopy 62(3):341-352.
    • (2013) Microscopy , vol.62 , Issue.3 , pp. 341-352
    • Tsuji, T.1    Yoshitomi, H.2    Usukura, J.3
  • 175
    • 59649102668 scopus 로고    scopus 로고
    • Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)
    • Ulbrich K, Hekmatara T, Herbert E, Kreuter J. 2009. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm 71(2):251-256.
    • (2009) Eur J Pharm Biopharm , vol.71 , Issue.2 , pp. 251-256
    • Ulbrich, K.1    Hekmatara, T.2    Herbert, E.3    Kreuter, J.4
  • 176
    • 84859553266 scopus 로고    scopus 로고
    • Pulmonary administration of interferon Beta-1a-fc fusion protein in non-human primates using an immunoglobulin transport pathway
    • Vallee S, Rakhe S, Reidy T, Walker S, Lu Q, Sakorafas P, Low S, Bitonti A. 2012. Pulmonary administration of interferon Beta-1a-fc fusion protein in non-human primates using an immunoglobulin transport pathway. J Interferon Cytokine Res 32(4):178-184.
    • (2012) J Interferon Cytokine Res , vol.32 , Issue.4 , pp. 178-184
    • Vallee, S.1    Rakhe, S.2    Reidy, T.3    Walker, S.4    Lu, Q.5    Sakorafas, P.6    Low, S.7    Bitonti, A.8
  • 178
    • 33747349484 scopus 로고    scopus 로고
    • Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide
    • Vlahov IR, Santhapuram HKR, Kleindl PJ, Howard SJ, Stanford KM, Leamon CP. 2006. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide. Bioorg Med Chem Lett 16(19):5093-5096.
    • (2006) Bioorg Med Chem Lett , vol.16 , Issue.19 , pp. 5093-5096
    • Vlahov, I.R.1    Santhapuram, H.K.R.2    Kleindl, P.J.3    Howard, S.J.4    Stanford, K.M.5    Leamon, C.P.6
  • 179
    • 0034734960 scopus 로고    scopus 로고
    • Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
    • Vyas SP, Sihorkar V. 2000. Endogenous carriers and ligands in non-immunogenic site-specific drug delivery. Adv Drug Deliv Rev 43(2-3):101-164.
    • (2000) Adv Drug Deliv Rev , vol.43 , Issue.2-3 , pp. 101-164
    • Vyas, S.P.1    Sihorkar, V.2
  • 180
    • 77951743418 scopus 로고    scopus 로고
    • Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites
    • Wang GP, Guan YS, Jin XR, Jiang SS, Lu ZJ, Wu Y, Li Y, Li M, Luo F. 2010. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites. J Gastroenterol Hepatol 25(5):985-990.
    • (2010) J Gastroenterol Hepatol , vol.25 , Issue.5 , pp. 985-990
    • Wang, G.P.1    Guan, Y.S.2    Jin, X.R.3    Jiang, S.S.4    Lu, Z.J.5    Wu, Y.6    Li, Y.7    Li, M.8    Luo, F.9
  • 181
    • 79960363229 scopus 로고    scopus 로고
    • More effective nanomedicines through particle design
    • Wang J, Byrne JD, Napier ME, DeSimone JM. 2011. More effective nanomedicines through particle design. Small 7(14):1919-1931.
    • (2011) Small , vol.7 , Issue.14 , pp. 1919-1931
    • Wang, J.1    Byrne, J.D.2    Napier, M.E.3    DeSimone, J.M.4
  • 183
    • 0344876636 scopus 로고    scopus 로고
    • Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas
    • Weaver M, Laske D. 2003. Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. J Neurooncol 65(1):3-13.
    • (2003) J Neurooncol , vol.65 , Issue.1 , pp. 3-13
    • Weaver, M.1    Laske, D.2
  • 184
  • 185
    • 34848911993 scopus 로고    scopus 로고
    • Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil
    • Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ. 2007. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharm Sci 10(3):350-357.
    • (2007) J Pharm Pharm Sci , vol.10 , Issue.3 , pp. 350-357
    • Wu, J.1    Lu, Y.2    Lee, A.3    Pan, X.4    Yang, X.5    Zhao, X.6    Lee, R.J.7
  • 187
    • 58849142161 scopus 로고    scopus 로고
    • A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages
    • Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng J-X, Low PS. 2009. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113(2):438-446.
    • (2009) Blood , vol.113 , Issue.2 , pp. 438-446
    • Xia, W.1    Hilgenbrink, A.R.2    Matteson, E.L.3    Lockwood, M.B.4    Cheng, J.-X.5    Low, P.S.6
  • 188
    • 80051552722 scopus 로고    scopus 로고
    • Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside
    • Yang F, Jin C, Jiang Y, Li J, Di Y, Ni Q, Fu D. 2011. Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside. Cancer Treat Rev 37(8):633-642.
    • (2011) Cancer Treat Rev , vol.37 , Issue.8 , pp. 633-642
    • Yang, F.1    Jin, C.2    Jiang, Y.3    Li, J.4    Di, Y.5    Ni, Q.6    Fu, D.7
  • 189
    • 34247249415 scopus 로고    scopus 로고
    • Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates
    • Yang J, Chen H, Vlahov IR, Cheng J-X, Low PS. 2007. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates. J Pharmacol Exp Ther 321(2):462-468.
    • (2007) J Pharmacol Exp Ther , vol.321 , Issue.2 , pp. 462-468
    • Yang, J.1    Chen, H.2    Vlahov, I.R.3    Cheng, J.-X.4    Low, P.S.5
  • 190
    • 84880182345 scopus 로고    scopus 로고
    • nab-Paclitaxel mechanisms of action and delivery
    • Yardley D. 2013. nab-Paclitaxel mechanisms of action and delivery. J Control Release 170(3):365-372.
    • (2013) J Control Release , vol.170 , Issue.3 , pp. 365-372
    • Yardley, D.1
  • 192
    • 8544219695 scopus 로고    scopus 로고
    • Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate
    • Yoo HS, Park TG. 2004. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 100(2):247-256.
    • (2004) J Control Release , vol.100 , Issue.2 , pp. 247-256
    • Yoo, H.S.1    Park, T.G.2
  • 193
    • 0031903379 scopus 로고    scopus 로고
    • Transvascular drug delivery in solid tumors
    • Yuan F. 1998. Transvascular drug delivery in solid tumors. Semin Radiat Oncol 8(3):164-175.
    • (1998) Semin Radiat Oncol , vol.8 , Issue.3 , pp. 164-175
    • Yuan, F.1
  • 194
  • 196
    • 59849093173 scopus 로고    scopus 로고
    • Membrane transporters and folate homeostasis: Intestinal absorption and transport into systemic compartments and tissues
    • Zhao R, Matherly LH, Goldman ID. 2009. Membrane transporters and folate homeostasis: Intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med 11:e4.
    • (2009) Expert Rev Mol Med , vol.11
    • Zhao, R.1    Matherly, L.H.2    Goldman, I.D.3
  • 198
    • 29144450682 scopus 로고    scopus 로고
    • Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents
    • Zheng G, Chen J, Li H, Glickson JD. 2005. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci USA 102(49):17757-17762.
    • (2005) Proc Natl Acad Sci USA , vol.102 , Issue.49 , pp. 17757-17762
    • Zheng, G.1    Chen, J.2    Li, H.3    Glickson, J.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.